COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS

Bavarian Nordic seeks EU approval to extend mpox vaccine to adolescents

"Children and adolescents are disproportionally affected by mpox in the ongoing outbreak in Africa, highlighting the importance and urgency to broaden the access to vaccines and therapies for this vulnerable population," Bavarian CEO Paul Chaplin said in a statement.

More in COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS

UK pledges £160 million to global vaccine drive

"Our £160 million pledge will support CEPI's vital work to cut vaccine development to 100 days and protect us all against future health threats".
IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica

The commencement of phase-II/III study of BBV87 in Costa Rica is a milestone and a first step towards developing a promising vaccine candidate against Chikungunya, an exhausting disease.
UK study into mixing Covid-19 vaccines to include Novavax, Moderna jabs

The mixing and matching doses could help countries weather vaccine supply shortages.
Japan scientists win backing for work on potential Nipah vaccine

A global coalition set up to fight emerging epidemics has struck a $31 million deal with scientists at Japan's University of Tokyo to speed up work on a vaccine against a brain-damaging disease caused by the Nipah virus.